Post-thrombotic syndrome secondary prevention

Revision as of 15:04, 28 March 2025 by Badgettrg (talk | contribs)
Jump to navigation Jump to search

Post-thrombotic syndrome Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Post-thrombotic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Social Impact

Case Studies

Case #1

Post-thrombotic syndrome secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-thrombotic syndrome secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-thrombotic syndrome secondary prevention

CDC on Post-thrombotic syndrome secondary prevention

Post-thrombotic syndrome secondary prevention in the news

Blogs on Post-thrombotic syndrome secondary prevention

Directions to Hospitals Treating Post-thrombotic syndrome

Risk calculators and risk factors for Post-thrombotic syndrome secondary prevention

Endovascular stenting of the iliac vein may help.[1]

References

  1. Rossi, Fabio H.; Kambara, Antonio M.; Izukawa, Nilo M.; Rodrigues, Thiago O.; Rossi, Cybelle B.; Sousa, Amanda G.; Metzger, Patrick B.; Thorpe, Patricia E. (2018). "Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease". Journal of Vascular Surgery. Venous and Lymphatic Disorders. 6 (2): 183–191. doi:10.1016/j.jvsv.2017.11.003. ISSN 2213-3348. PMID 29292114.